You are here

Clinical Trials: Cord Blood

Conditions:   Cerebral Palsy;   Child Development
Intervention:   Biological: allogeneic cord blood transplantation
Sponsor:   Bundang CHA Hospital
Recruiting - verified April 2017
Condition:   Hematologic Disorders
Intervention:   Device: Miltenyi CliniMACS® CD34 Reagent System
Sponsor:   University of Colorado, Denver
Not yet recruiting - verified March 2017
Condition:   Hematopoietic/Lymphoid Cancer
Interventions:   Drug: Busulfan;   Drug: Rituximab;   Drug: ATG;   Drug: Fludarabine;   Drug: Clofarabine;   Radiation: Total Body Irradiation;   Procedure: Cord Blood Transplant;   Drug: Mycofenolate mofetil;   Drug: Tacrolimus;   Drug: G-CSF;   Drug: Melphalan;   Drug: Cyclophosphamide;   Drug: Mesna
Sponsors:   M.D. Anderson Cancer Center;   Mesoblast, Inc.
Not yet recruiting - verified March 2017
Condition:   Cerebral Palsy
Intervention:   Biological: Matched sibling donor cord blood cell infusion
Sponsors:   Murdoch Childrens Research Institute;   The Royal Children's Hospital Melbourne;   Children's Health Queensland;   Monash Health;   Sydney Children's Network;   Cerebral Palsy Alliance
Recruiting - verified March 2017
Conditions:   Acute Myeloid Leukemia;   Acute Lymphocytic Leukemia;   Myelodysplastic Syndrome;   Non-hodgkin Lymphoma;   Chronic Lymphocytic Leukemia
Interventions:   Drug: Cyclophosphamide;   Drug: Tacrolimus;   Drug: Mycophenolate mofetil;   Other: Haploidentical Stem Cell Transplantation
Sponsor:   Loyola University
Recruiting - verified March 2017
Conditions:   B-Lymphoid Malignancies;   Acute Lymphocytic Leukemia;   Chronic Lymphocytic Leukemia;   Non-hodgkin Lymphoma
Interventions:   Drug: Fludarabine;   Drug: Cyclophosphamide;   Drug: Mesna;   Biological: iC9/CAR.19/IL15-Transduced CB-NK Cells;   Drug: AP1903
Sponsors:   M.D. Anderson Cancer Center;   Bellicum Pharmaceuticals
Not yet recruiting - verified April 2017
Condition:   B-Cell Non-Hodgkin Lymphoma
Interventions:   Biological: NK Cells;   Drug: Rituximab;   Drug: Carmustine;   Drug: Etoposide;   Drug: Cytarabine;   Drug: Melphalan;   Drug: Lenalidomide 10Mg Capsule;   Drug: G-CSF;   Biological: Auto SCT;   Other: Apheresis
Sponsor:   M.D. Anderson Cancer Center
Not yet recruiting - verified March 2017
Conditions:   Acute Leukemia;   Immune Deficiency Disorder;   Congenital Hematological Disorder;   Metabolism Disorder;   Aplastic Anemia;   Myelodysplastic Syndromes;   Chronic Leukemia;   Lymphoma;   Multiple Myeloma;   Solid Tumor
Interventions:   Radiation: Total Body Irradiation 1200 cGy;   Radiation: Total Body Irradiation 200 cGy;   Drug: Cyclophosphamide;   Drug: Mesna;   Procedure: Cord Blood Infusion;   Drug: Busulfan;   Drug: Fludarabine;   Drug: Melphalan
Sponsor:   University of Rochester
Recruiting
Conditions:   Alpha Thalassemia Major;   Hemoglobinopathy; With Thalassemia;   Hemoglobinopathies;   Fetal Anemia;   Fetal Hydrops;   Alpha; Thalassemia;   Thalassemia Major;   Thalassemia Alpha;   A-Thalassemia
Intervention:   Biological: in utero hematopoietic stem cell transplantation
Sponsor:   University of California, San Francisco
Recruiting
Conditions:   Stroke;   Stroke, Acute;   Brain Injury, Acute
Interventions:   Biological: Umbilical Cord Blood;   Other: Placebo
Sponsors:   Joanne Kurtzberg, MD;   The Marcus Foundation;   Emory University;   M.D. Anderson Cancer Center
Recruiting - verified March 2017

Pages